![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United Kingdom | Publication | December 2023
On December 7, 2023, the Regulator published the text of a speech recently given by its chief executive, Nausicaa Delfas, to the UK Finance Corporate Finance Committee dinner.
Ms Delfas highlighted that the Regulator’s anti-avoidance powers have been enhanced through the new criminal sanctions enacted under the Pension Schemes Act 2021. In relation to industry concerns about the scope of the criminal sanctions, she referred to the Regulator's published policy on their use, which she said means that the Regulator will only consider using them "in the most egregious cases".
Overall, Ms Delfas outlined three "takeaways" for corporates engaged in M&A activity.
Ms Delfas noted the government's intention to extend the notifiable events regime to include a new requirement for a declaration of intent to be submitted to the Regulator and trustees. The government will apparently bring forward the long-awaited final regulations “in due course".
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023